Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 2
2000 2
2001 3
2002 4
2003 4
2004 1
2005 3
2006 4
2007 2
2008 1
2009 3
2010 2
2012 1
2013 2
2014 2
2015 2
2016 1
2017 1
2018 1
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé B, Sfakianos JP, Ranti D, Daza J, Bieber C, Charap A, Hammer C, Banchereau R, Farkas AM, Ruan DF, Izadmehr S, Geanon D, Kelly G, de Real RM, Lee B, Beaumont KG, Shroff S, Wang YA, Wang YC, Thin TH, Garcia-Barros M, Hegewisch-Solloa E, Mace EM, Wang L, O'Donnell T, Chowell D, Fernandez-Rodriguez R, Skobe M, Taylor N, Kim-Schulze S, Sebra RP, Palmer D, Clancy-Thompson E, Hammond S, Kamphorst AO, Malmberg KJ, Marcenaro E, Romero P, Brody R, Viard M, Yuki Y, Martin M, Carrington M, Mehrazin R, Wiklund P, Mellman I, Mariathasan S, Zhu J, Galsky MD, Bhardwaj N, Horowitz A. Salomé B, et al. Among authors: skobe m. Cancer Cell. 2022 Sep 12;40(9):1027-1043.e9. doi: 10.1016/j.ccell.2022.08.005. Cancer Cell. 2022. PMID: 36099881 Free PMC article.
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.
Clement CC, D'Alessandro A, Thangaswamy S, Chalmers S, Furtado R, Spada S, Mondanelli G, Ianni F, Gehrke S, Gargaro M, Manni G, Cara LCL, Runge P, Tsai WL, Karaman S, Arasa J, Fernandez-Rodriguez R, Beck A, Macchiarulo A, Gadina M, Halin C, Fallarino F, Skobe M, Veldhoen M, Moretti S, Formenti S, Demaria S, Soni RK, Galarini R, Sardella R, Lauvau G, Putterman C, Alitalo K, Grohmann U, Santambrogio L. Clement CC, et al. Among authors: skobe m. Nat Commun. 2021 Jul 21;12(1):4447. doi: 10.1038/s41467-021-24785-3. Nat Commun. 2021. PMID: 34290243 Free PMC article.
Lymphatic vessels and cancer.
Skobe M. Skobe M. Lymphat Res Biol. 2012 Sep;10(3):96. doi: 10.1089/lrb.2012.1032. Lymphat Res Biol. 2012. PMID: 22984904 No abstract available.
Lymphangiogenesis and tumor metastasis.
Pepper MS, Tille JC, Nisato R, Skobe M. Pepper MS, et al. Among authors: skobe m. Cell Tissue Res. 2003 Oct;314(1):167-77. doi: 10.1007/s00441-003-0748-7. Epub 2003 Jul 18. Cell Tissue Res. 2003. PMID: 12883995 Review.
Lymphatic vessel activation in cancer.
Das S, Skobe M. Das S, et al. Among authors: skobe m. Ann N Y Acad Sci. 2008;1131:235-41. doi: 10.1196/annals.1413.021. Ann N Y Acad Sci. 2008. PMID: 18519976 Review.
Lymphatic vessel activation in cancer.
Cassella M, Skobe M. Cassella M, et al. Among authors: skobe m. Ann N Y Acad Sci. 2002 Dec;979:120-30. doi: 10.1111/j.1749-6632.2002.tb04873.x. Ann N Y Acad Sci. 2002. PMID: 12543722 Review.
45 results